𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Comparative in vitro cytotoxicity of taxol and Taxotere against cisplatin-sensitive and-resistant human ovarian carcinoma cell lines

✍ Scribed by Lloyd R. Kelland; George Abel

Publisher
Springer
Year
1992
Tongue
English
Weight
801 KB
Volume
30
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparative cytotoxicity of CI-973, cisp
Comparative cytotoxicity of CI-973, cisplatin, carboplatin and tetraplatin in human ovarian carcinoma cell lines
✍ R. P. Perez; P. J. O'Dwyer; L. M. Handel; R. F. Ozols; T. C. Hamilton 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 French ⚖ 528 KB

## Abstract The clinical efficacy of cisplatin‐based chemotherapy for ovarian cancer is frequently compromised by drug resistance or dose‐limiting renal and neurologic toxicities. CI‐973 (NK‐121), a 2‐methyl‐1, 4‐butanediamine analogue of carboplatin, has shown little nephro‐and neuro‐toxicity in p

Hyperphosphorylation of replication prot
Hyperphosphorylation of replication protein A in cisplatin-resistant and -sensitive head and neck squamous cell carcinoma cell lines
✍ Karoline C. Manthey; Jason G. Glanzer; Diana D. Dimitrova; Greg G. Oakley 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 419 KB 👁 3 views

## Abstract ## Background Resistance to chemotherapy is a major limitation in the treatment of head and neck squamous cell carcinomas (HNSCCs), accounting for high mortality rates in patients. Here, we investigated the role of replication protein A (RPA) in cisplatin and etoposide resistance. ##

Altered adhesion properties and alpha v
Altered adhesion properties and alpha v integrin expression in a cisplatin-resistant human ovarian carcinoma cell line
✍ Sylvie Maubant; Séverine Cruet-Hennequart; Laurent Poulain; Franck Carreiras; Fr 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 416 KB

## Abstract In order to elucidate the mechanisms underlying the development of chemoresistance in ovarian cancer, we have previously established the IGROV1‐R10 cisplatin‐resistant cell line by mimicking a clinical protocol of drug administration on IGROV1 human ovarian carcinoma cells. Both IGROV1

Comparison of protein kinase C activity
Comparison of protein kinase C activity and isoform expression in cisplatin-sensitive and -resistant ovarian carcinoma cells
✍ Alakananda Basu; Kelly M. Weixel 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 514 KB

Cellular sensitivity to cis-diamminedichloroplatinum(ll) (cDDP) can be regulated by protein kinase C (PKC) signal transduction pathway. Activators of PKC were shown to enhance the sensitivity of human ovarian carcinoma 2008 cells to cDDP. We have examined whether or not the PKC signal transduction p

Differential expression of collateral se
Differential expression of collateral sensitivity or resistance to cisplatin in human bladder carcinoma cell lines pre-exposed in vitro to either X-irradiation or cisplatin
✍ Philip Bedford; Sharon A. Shellard; M. Claire Walker; Richard D. H. Whelan; John 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 French ⚖ 632 KB

Two sublines were derived from a human bladder carcinoma continuous cell line (RTI 12-P), one by exposure to fractionated X-irradiation (RTI IZ-DXRa) and the other by continuous exposure to cisplatin (RT 112-CP). RTI I2-DXR8 cells were I .6to 2-fold more sensitive to cisplatin and 2 analogues, carbo